关注
Corey S. Davis
Corey S. Davis
Network for Public Health Law
在 networkforphl.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Today’s fentanyl crisis: Prohibition’s Iron Law, revisited
L Beletsky, CS Davis
International Journal of Drug Policy 46, 156-159, 2017
2122017
Association between medical cannabis laws and opioid overdose mortality has reversed over time
CL Shover, CS Davis, SC Gordon, K Humphreys
Proceedings of the National Academy of Sciences 116 (26), 12624-12626, 2019
2112019
Opioid-overdose laws association with opioid use and overdose mortality
C McClellan, BH Lambdin, MM Ali, R Mutter, CS Davis, E Wheeler, ...
Addictive behaviors 86, 90-95, 2018
2082018
Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts
CS Davis, S Ruiz, P Glynn, G Picariello, AY Walley
American journal of public health 104 (8), e7-e9, 2014
1872014
Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA.
CS Davis, S Burris, J Kraut-Becher, KG Lynch, D Metzger
American Journal of Public Health 95 (2), 233, 2005
1812005
Legal changes to increase access to naloxone for opioid overdose reversal in the United States
CS Davis, D Carr
Drug and alcohol dependence 157, 112-120, 2015
1752015
Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review
CS Davis, AJ Lieberman, H Hernandez-Delgado, C Suba
Drug and alcohol dependence 194, 166-172, 2019
1692019
State legal innovations to encourage naloxone dispensing
C Davis, D Carr
Journal of the American Pharmacists Association 57 (2), S180-S184, 2017
1352017
Orienting patients to greater opioid safety: models of community pharmacy-based naloxone
TC Green, EF Dauria, J Bratberg, CS Davis, AY Walley
Harm reduction journal 12, 1-9, 2015
1182015
State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies
J Xu, CS Davis, M Cruz, P Lurie
Drug and alcohol dependence 189, 37-41, 2018
1132018
Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration
CS Davis, D Carr, JK Southwell, L Beletsky
American journal of public health 105 (8), 1530-1537, 2015
1022015
Emergency medical services naloxone access: a national systematic legal review
CS Davis, JK Southwell, VR Niehaus, AY Walley, MW Dailey
Academic Emergency Medicine 21 (10), 1173-1177, 2014
982014
Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements
CS Davis, D Carr
Drug and alcohol dependence 163, 100-107, 2016
972016
Changing law from barrier to facilitator of opioid overdose prevention
C Davis, D Webb, S Burris
Journal of Law, Medicine & Ethics 41 (S1), 33-36, 2013
942013
The law (and politics) of safe injection facilities in the United States
L Beletsky, CS Davis, E Anderson, S Burris
American Journal of Public Health 98 (2), 2008
912008
Prescribe to prevent: overdose prevention and naloxone rescue kits for prescribers and pharmacists
JK Lim, JP Bratberg, CS Davis, TC Green, AY Walley
Journal of addiction medicine 10 (5), 300, 2016
872016
Association of pregnancy and insurance status with treatment access for opioid use disorder
SW Patrick, MR Richards, WD Dupont, E McNeer, MB Buntin, PR Martin, ...
JAMA network open 3 (8), e2013456-e2013456, 2020
842020
Opioid policy changes during the COVID-19 pandemic-and beyond
CS Davis, EA Samuels
Journal of Addiction Medicine, 2020
762020
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19
CS Davis, EA Samuels
International Journal of Drug Policy 93, 102905, 2021
732021
Association of Medicaid expansion with opioid overdose mortality in the United States
N Kravitz-Wirtz, CS Davis, WR Ponicki, A Rivera-Aguirre, BDL Marshall, ...
JAMA network open 3 (1), e1919066-e1919066, 2020
712020
系统目前无法执行此操作,请稍后再试。
文章 1–20